1Interpretation of American Society of Hematology 2019 Guidelines for Immune Thrombocytopenia (the part for children)XU Yu-ting, HU QunGUIDELINES UNDERSTANDING81-852Interpretation of Updated International Consensus Report on the Investigation and Management of Primary Immune Thrombocytopenia (the part for children, Version 2019)XU Qian, ZHOU MinGUIDELINES UNDERSTANDING86-89,1033Research progress on the pathogenesis of pediatric immune thrombocytopeniaXIE Xing-juan, CHEN Zhen-pingSYMPOSIUM90-944Identifying primary immunodeficiencies in children with chronic immune thrombocytopeniaZHANG Jia-lu, WU Run-huiSYMPOSIUM94-995Quality of life of children with primary immune thrombocytopenia and its influencing factorsZHANG Heng, WEI Yu-ting, FANG Yong-junSYMPOSIUM99-1036Efficacy and safety of recombinant human thrombopoietin in the treatment of primary immune thrombocytopenia in children :A systematic review and meta-analysisLI Kun, YANG Yu-xian, CAO BinORIGINAL CONTRIBUTION104-1097Survival status of children with β-thalassemia major in ZhuhaiDUAN Li, LI Tong, WANG FengORIGINAL CONTRIBUTION110-1148Clinical features and gene analysis of three cases of immunodeficiency-centromeric instability-facial anomalies syndromeYANG Mi, SUN Bi-jun, WANG Wen-jieORIGINAL CONTRIBUTION115-1209Interventional vascular complications in children with common congenital heart disease: A report of 4 casesLUO Gang, ZHAO Hong-wei, PAN Si-linORIGINAL CONTRIBUTION121-12410Alport syndrome with the onset of steroid-resistant nephrotic syndrome : A clinical analysis of 15 casesTAN Jun-jie, ZHANG Yao, YU Sheng-youORIGINAL CONTRIBUTION125-12911Study on the attention of children with allergic rhinitis in Beijing based on Baidu indexLIN Feng, PANG Chong, GU Qing-longORIGINAL CONTRIBUTION130-135 